| BGN | biglycan |
| SASP | senescence-associated secretory phenotype |
| ECM | extracellular matrix |
| Dox | doxorubicin |
| Fsk | forskolin |
| Dex | dexamethasone |
| AKT | serine-threonine kinase, protein kinase B |
| mTOR | mammalian target of rapamycin |
| IL6 | interleukin 6 |
| Ccl2 | CC motif chemokine ligand 2 |
| Tgfβ1 | transforming growth factor beta 1 |
| TNFα | palmitic acid |
| p21 | cyclin-dependent kinase inhibitor 1A (CDKN1A) |
| p16 | cyclin-dependent kinase inhibitor 2A (CDKN2A) |
| ROS | reactive oxygen species |
| MyoD | myoblast determination protein |
| MyHC | myosin heavy chain |
| MuRF1 | muscle RING finger 1 |
| Atrogin | muscle atrophy F-box (MAFbx) |
| Foxo3 | forkhead box O3 |
| GAPDH | glyceraldehyde 3-phosphate dehydrogenase |
| Hprt | hypoxanthine phosphoribosyltransferase |
| L32 | ribosomal protein L32 |